Oramed Granted NASH Patent in Europe

Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the European Patent Office has granted the Company the…

Continue Reading Oramed Granted NASH Patent in Europe